학술논문

Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs
Document Type
Article
Source
The American Journal of Surgical Pathology; April 2023, Vol. 47 Issue: 4 p490-496, 7p
Subject
Language
ISSN
01475185; 15320979
Abstract
Sertoli-Leydig cell tumors (SLCTs) are uncommon ovarian sex cord-stromal neoplasms which are currently classified into well, moderately, and poorly differentiated and retiform types. Well-differentiated SLCT is the least common and typically occurs in pure form, whereas moderately and poorly differentiated and retiform types often comprise a morphologic spectrum with an admixture of all 3. DICER1pathogenic variants are very common in SLCTs but, as far as we are aware, have not been reported in well-differentiated neoplasms, although the number of cases studied is small due to the rarity of this neoplasm. We undertook DICER1molecular testing in a cohort of 18 well-differentiated SLCTs and show all these to be DICER1wild-type. None of the cases harbored the p.FOXL2C134W hotspot mutation. Based upon the DICER1molecular results, together with morphologic observations, we propose that well-differentiated SLCT is an unrelated neoplasm to the more common moderately/poorly differentiated and retiform SLCTs and is a fundamentally distinct and unrelated tumor type within the ovarian sex cord-stromal tumor family. The implications for tumor nomenclature and recommendations for future tumor classification are discussed within the context of tumors collectively known as SLCTs.